Effectiveness and Outcome of Methylprednisolone Versus Hydrocortisone in Treatment of Acute Respiratory Distress Syndrome
Al-Azhar International Medical Journal · 01.11.2026 · 2026 (11) · 237-241
DOI: 10.21608/aimj.2026.477635.3404 ↗Kurz gefasst
Fachartikel in der Zeitschrift Al-Azhar International Medical Journal, online erschienen am 01.11.2026. Verfasst von Waleed Saber Elsayed und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Acute respiratory-distress-syndrome (ARDS) is a severe inflammatory lung disease characterized by generalized alveolar injury, impaired oxygenation, and high death rates among critically ill patients. Corticosteroids have been proposed as adjunctive therapy because of their anti-inflammatory effects and potential to accelerate the resolution of pulmonary injury. However, uncertainty persists regarding the comparative effectiveness of different corticosteroid regimens in ARDS.
Aim
To compare the effectiveness and clinical outcomes of methylprednisolone versus hydrocortisone in the treatment of patients with ARDS.
Methods
This prospective study was conducted in the intensive care units of Al-Azhar University Hospitals, Cairo, Egypt. The study included 60 adult patients diagnosed with ARDS according to the Berlin definition. Patients were randomly assigned to two groups. Group M received methyl-prednisolone, while Group H received hydrocortisone. All patients received standard ARDS management. The primary outcome was improvement in gas exchange assessed by the PaO₂/FiO₂ ventilation ratio.
Results
Both treatment groups demonstrated improvement in oxygenation during the study period. Patients treated with methylprednisolone expressed greater improvement in the PaO₂/FiO₂-ratio from day 2 to day 7 compared with the hydrocortisone group. Reductions in inflammatory markers, particularly C-reactive protein and D-dimer, were more pronounced in the methylprednisolone group.
Conclusion
Methylprednisolone may provide greater improvement in oxygenation and inflammatory response compared with hydrocortisone in patients with ARDS.
Zitieren
APA
Elsayed, W. S., Abdelrahman, A. S., & Fathy, N. I. (2026). Effectiveness and Outcome of Methylprednisolone Versus Hydrocortisone in Treatment of Acute Respiratory Distress Syndrome. Al-Azhar International Medical Journal, 2026(11), 237-241. https://doi.org/10.21608/aimj.2026.477635.3404
Vancouver
Elsayed WS, Abdelrahman AS, Fathy NI. Effectiveness and Outcome of Methylprednisolone Versus Hydrocortisone in Treatment of Acute Respiratory Distress Syndrome. Al-Azhar International Medical Journal. 2026;2026(11):237-241. doi:10.21608/aimj.2026.477635.3404
BibTeX
@article{Elsayed2026,
author = {Elsayed, Waleed Saber and Abdelrahman, Ahmed Saied and Fathy, Nabil Ibrahim},
title = {Effectiveness and Outcome of Methylprednisolone Versus Hydrocortisone in Treatment of Acute Respiratory Distress Syndrome},
journal = {Al-Azhar International Medical Journal},
year = {2026},
volume = {2026},
number = {11},
pages = {237--241},
doi = {10.21608/aimj.2026.477635.3404}
}
EUVIMED